Brahmana Askandar Tjokroprawiro

ORCID: 0000-0003-1658-3477 · 4 papers in corpus
2025
Comparison of PD-L1, CTR-1, VEGF, and p53 expression in sensitive and resistant epithelial ovarian cancer (EOC) patients to platinum-based chemotherapy.
Narra J ·doi:10.52225/narra.v5i1.1419

The current standard treatment for ovarian cancer is a combination of cytoreductive surgery and platinum-based chemotherapy; however, many patients develop resistance, leading to a high recurrence rate. The aim of this study was to analyze …

2024
Clinicopathological analysis of giant ovarian tumors.
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2024.100318

ObjectiveThis study aims to analyze giant ovarian tumors' clinical and pathological characteristics.Material and methodsThis was an analytical observational study. Medical records of all patients with giant ovarian tumors who underwent surg…

article 2024
Huge endometrioma mimicking ovarian malignancy: report of three cases, what radiology should considered?
·doi:10.3802/jgo.2024.35.s2.p38
2023
Advanced Stage Clear Cell Ovarian Carcinoma Mimicking Uterine Sarcoma Without Gross Residual Tumor During Primary Surgery: A Case Report.
Clinical medicine insights. Case reports ·doi:10.1177/11795476231166623

BackgroundClear cell ovarian carcinoma is rare and accounts for 1%-12% of ovarian epithelial carcinomas, depending on ethnicity. The prevalence of clear cell ovarian carcinoma in Asian, White, and Black women is 11.1%%, 4.8%, and 3.1%, resp…